Study of Non-alcoholic fatty liver disease among chronic kidney disease patients by Controlled attenuation parameter

Abstract

Preliminary data suggest an association between chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD). The aim of this study was to further investigate the association between NAFLD and kidney function Liver stiffness measurement was used to detect liver fibrosis and CAP (controlled attenuation parameter) was used to detect and quantify liver steatosis (Fibroscan®). NAFLD was defined by CAP values ≥238 dB/m. A total of 40 subjects were enrolled in the study. Subjects are divided in two groups, Group A (30) non-diabetic CKD patiens not on dialysis (19) males and (11) females, and Group B (10) normal healthy subjects matched for age and sex (7) males and (3) females as a control group.